Effects of intravenous infusions of PYY3-36 and GLP-1, as monoinfusion and in combination, on ad libitum energy intake in healthy obese subjects

被引：0
|
作者：
Schmidt, J. B. [1 ]
Gregersen, N. T. [1 ]
Pedersen, S. [1 ]
Holst, J. J. [2 ]
Schwartz, T. [3 ]
Astrup, A. [1 ]
Sjodin, A. [1 ]
机构：
[1] Univ Copenhagen, Dept Human Nutr, Fac Sci, DK-1168 Copenhagen, Denmark
[2] Univ Copenhagen, Dept Biomed Sci, Fac Hlth Sci, DK-1168 Copenhagen, Denmark
[3] Univ Copenhagen, Dept Neurosci & Pharmacol, Fac Hlth Sci, DK-1168 Copenhagen, Denmark
来源：
REGULATORY PEPTIDES | 2012年 / 177卷
关键词：
D O I：
10.1016/j.regpep.2012.05.071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 33 条
  • [1] Serum lipase activity and concentration during intravenous infusions of GLP-1 and PYY3-36 and after ad libitum meal ingestion in overweight men
    Schmidt, Julie B.
    Sjodin, Anders
    Stevner, Lene S.
    Ritz, Christian
    Michaelsen, Natasha B.
    Thomsen, Anne B.
    Holst, Jens J.
    Astrup, Arne
    PHYSIOLOGICAL REPORTS, 2016, 4 (18):
  • [2] Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men
    Schmidt, Julie Berg
    Gregersen, Nikolaj Ture
    Pedersen, Sue D.
    Arentoft, Johanne L.
    Ritz, Christian
    Schwartz, Thue W.
    Holst, Jens Juul
    Astrup, Arne
    Sjodin, Anders
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2014, 306 (11): : E1248 - E1256
  • [3] Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: a proof of concept study in healthy subjects
    Arbit, E.
    Poller, B.
    Ganzoni, C.
    Gass, S.
    Gomez-Orellana, I.
    Drewe, J.
    Beglinger, C.
    DIABETOLOGIA, 2007, 50 : S52 - S52
  • [4] Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: A proof-of-concept study in healthy subjects
    Beglinger, C.
    Poller, B.
    Arbit, E.
    Ganzoni, C.
    Gass, S.
    Gomez-Orellana, I.
    Drewe, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (04) : 468 - 474
  • [5] Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects
    Sloth, Birgitte
    Holst, Jens Juul
    Flint, Anne
    Gregersen, Nikolaj Ture
    Astrup, Arne
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (04): : E1062 - E1068
  • [6] Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males
    Sloth, Birgitte
    Davidsen, Louise
    Holst, Jens Juul
    Flint, Anne
    Astrup, Arne
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (02): : E604 - E609
  • [7] Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects (vol 292, pg E1062, 2007)
    Sloth, B.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (06): : E1847 - E1847
  • [8] PYY3-36 and Hunger Responses to Exercise in Obese Adolescent Girls: Which Effects on Effective Energy Intake?
    Schwartz, Chloe
    Thivel, David
    PEDIATRIC EXERCISE SCIENCE, 2015, 27 (01) : 175 - 176
  • [9] The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers
    Tan, Tricia
    Behary, Preeshila
    Tharakan, George
    Minnion, James
    Al-Najim, Werd
    Albrechtsen, Nicolai J. Wewer
    Holst, Jens J.
    Bloom, Stephen R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (07): : 2364 - 2372
  • [10] Gastric distension does not affect the inhibitiory effect of PYY3-36 on food intake in healthy human subjects
    Degen, Lukas
    Cesena, Philipp
    Cesch, Sibylle
    Beglinger, Christoph
    GASTROENTEROLOGY, 2006, 130 (04) : A606 - A607
1234